SYRE Spyre Therapeutics, Inc.
Healthcare$73.78+0.00%OpenMarket Cap: $4.46B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$85.45
Target (Median)
$90.00
Target Range
$49.00 - $107.00
Upside from current price: 15.8%
Rating Distribution
0 Strong Buy17 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | Citigroup | maintain | Buy | Buy |
| 2026-05-06 | Stifel | maintain | Buy | Buy |
| 2026-04-17 | Jones Trading | maintain | Buy | Buy |
| 2026-04-14 | Deutsche Bank | maintain | Buy | Buy |
| 2026-04-14 | Baird | maintain | Outperform | Outperform |
| 2026-04-14 | Wedbush | maintain | Outperform | Outperform |
| 2026-04-14 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-04-13 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-04-13 | Jefferies | maintain | Buy | Buy |
| 2026-04-13 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.15 | $166.7K | 11 |
| Sun Dec 31 | $-3.58 | $200.0K | 10 |
| Mon Dec 31 | $-3.91 | $50.2M | 4 |
| Tue Dec 31 | $-3.89 | $121.0M | 4 |